← Back to Search

Risk Awareness Training for Alcoholism

N/A
Recruiting
Led By Mark Fillmore, PhD
Research Sponsored by Mark Fillmore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to follow up [monthly], up to 3 months
Awards & highlights

Summary

This trial will test if a special type of training can help people who have been caught driving under the influence of alcohol to better understand the risks associated with drinking.

Who is the study for?
This trial is for individuals who drive on a weekly basis and have had a valid driver's license for at least five years. It specifically targets DUI offenders to help them understand the risks of alcohol use. Pregnant or breastfeeding individuals, those with substance use disorders (excluding nicotine or caffeine), or with physical or psychiatric diseases cannot participate.
What is being tested?
The study is testing two types of training: performance feedback training and blood alcohol concentration discrimination training. The goal is to see if these methods can improve DUI offenders' awareness of the risks associated with drinking and driving.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience stress or discomfort when confronting their behaviors related to alcohol consumption.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to follow up [monthly], up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to follow up [monthly], up to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in alcohol consumption
Change in subjects perceive improvement in their interoceptive ability
Change in tonic alcohol cravings

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intoxicated risk awareness training sessionExperimental Treatment2 Interventions
Participants will complete an intoxicated risk awareness training session in which they receive a controlled alcohol dose with structured feedback and training to accurately appraise the impairing effects of alcohol and estimate their blood alcohol concentration (BAC).
Group II: Alcohol exposure onlyActive Control1 Intervention
Participants assigned to the alcohol-exposure-only condition undergo the same alcohol dose exposures over the session but receive a general body scan and do not receive feedback concerning BAC or performance.

Find a Location

Who is running the clinical trial?

Mark FillmoreLead Sponsor
2 Previous Clinical Trials
128 Total Patients Enrolled
1 Trials studying Alcoholism
28 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
823 Previous Clinical Trials
1,161,186 Total Patients Enrolled
433 Trials studying Alcoholism
778,467 Patients Enrolled for Alcoholism
Mark Fillmore, PhDPrincipal InvestigatorUniversity of Kentucky
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Blood alcohol concentration (BAC) discrimination training Clinical Trial Eligibility Overview. Trial Name: NCT05247788 — N/A
Alcoholism Research Study Groups: Alcohol exposure only, Intoxicated risk awareness training session
Alcoholism Clinical Trial 2023: Blood alcohol concentration (BAC) discrimination training Highlights & Side Effects. Trial Name: NCT05247788 — N/A
Blood alcohol concentration (BAC) discrimination training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05247788 — N/A
~55 spots leftby Nov 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top